News + media - Sedgwick
Skip to content
Latest Coronavirus updates from Sedgwick Back to business solutions

Posts related to ‘Drug abuse or misuse’

Search
Filter
  •  | 
View
Sedgwick edge
December 07, 2017
Edging up: Short takes on emerging industry issues – physical therapy costs, state legislative changes and fraud control

Rising physical therapy costs – Balancing the budget as price tags surge BY ROBIN BUSHVice President, Medical Networks, Sedgwick Employers and risk managers watching physical therapy spend rising may assume that the rising cost is because of increasi…

December 07, 2017
Sedgwick edge
December 07, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
Prescription drug (monitoring programs) + (the opioid epidemic)

For example, in Kentucky, Tennessee and New York, prescribers are legally required to check PDMP data when initially prescribing opioids. This has resulted in a decrease in the number of opioid prescriptions in each state of 8.5%, 7% and 9.5%, respec…

December 07, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
Article
November 08, 2017
Mike Merlino
SVP Medicare Compliance
Opioid reserves in Medicare set-asides a nationwide problem

Sedgwick SVP Medicare Compliance, Michael Merlino is featured in an article that focuses on how Medicare set-asides with money earmarked for opioids is drawing national attention. Mr. Merlino explains Medicare set-asides and the green light for futu…

November 08, 2017 by Mike Merlino, SVP Medicare Compliance
Article
November 07, 2017
Dr. Teresa Bartlett
Senior Medical Officer
Building better prescription drug practices

Sedgwick SVP Medical Quality, Dr. Teresa Bartlett shares highlights from her presentation at the IRMI Construction Risk Conference in an article entitled, “Building better prescription drug practices.” In the article, she talks about the size and sc…

November 07, 2017 by Dr. Teresa Bartlett, Senior Medical Officer
Blog
October 27, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
Safety made simple: National Prescription Drug Take Back Day

Sedgwick routinely reminds clients and colleagues about the U.S. Drug Enforcement Administration’s (DEA’s) National Prescription Drug Take Back Days. The next Take Back Day will be this Saturday, October 28 from 10 a.m. – 2 p.m. In 2010, the DEA st…

October 27, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
Blog
October 25, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
The pharmacist and the claim

Fostering awareness in the complex world of prescription drugs It is vital for a claims administrator to have pharmacists on staff because the current reality in workers’ compensation injury care is that prescription drug activity is a dangerous and…

October 25, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
Blog
September 29, 2017
Dr. Andrew Newhouse, Sedgwick pharmacist
The alarming facts about methadone

Methadone is an opioid medication most commonly used for detoxification, maintenance treatment of opioid addiction, and limited use for chronic pain. The drawbacks to its use stem from the risk of addiction and abuse with the medication, even at reco…

September 29, 2017 by Dr. Andrew Newhouse, Sedgwick pharmacist
Blog
September 14, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
A portrait of opioid use disorder

A portrait of opioid use disorder Read part one of Rachel's story here. Rachel was once a vibrant gardener, grandmother and worker. Regrettably, following an injury, she became one of a growing number of those suffering from opioid use disorder (…

September 14, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
Sedgwick edge
September 11, 2017
Bryon Bass
SVP Disability and Absence Management
Edging up: Short takes on emerging industry issues – government compliance updates, state legislation and drug law changes

ERISA changes being introduced BY BRYON BASSSVP, Disability and Absence Management, Sedgwick Several changes in the regulations governing claims and appeals under the Employee Retirement Income Security Act of 1974 (ERISA) became effective in January…

September 11, 2017 by Bryon Bass, SVP Disability and Absence Management
Blog
August 31, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
Rachel’s story: A portrait of opioid use disorder

Rachel enjoyed gardening and canning vegetables. She enjoyed cooking, taking walks and spending time with her grandchildren. After she was injured at work, she was optimistic about making a speedy recovery. She was 53 years old and had always stayed …

August 31, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
Article
August 22, 2017
Dr. Paul Peak
Assistant Vice President Clinical Pharmacy
More PBMs tackling opioids at the first fill as state comp laws evolve

Sedgwick AVP, Clinical Pharmacy, Dr. Paul Peak notes the risk for addiction increases with longer first fills and comments on a trend for the drug management firms to help enforce the laws. Some physicians are still not listening to what is being re…

August 22, 2017 by Dr. Paul Peak, Assistant Vice President Clinical Pharmacy
Blog
May 17, 2017
The basics of complex claims

Most workers’ compensation claims do not start out as complex. They become complex over time due to specific drivers that increase costs and duration. Being able to recognize and resolve these drivers at the right time will help reduce a claim’s like…

May 17, 2017
Blog
April 28, 2017
Andrew Newhouse, Sedgwick pharmacist
Tomorrow is National Prescription Drug Take-Back Day

The 2017 National Prescription Drug Take-Back Day is Saturday, April 29 from 10:00 a.m. – 2:00 p.m. The day was established in 2010 by the U.S. Drug Enforcement Administration (DEA) to help reduce prescription drug risks and promote safety. Accord…

April 28, 2017 by Andrew Newhouse, Sedgwick pharmacist
Blog
March 16, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
Slowly, steadily states striking against epidemic opioid issues

State governments are responding to the opioid epidemic. Recently, the New Jersey governor signed new legislation that limits prescribers’ capacity to provide first-time opioid prescriptions for more than five days. The New Jersey state senate passed…

March 16, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
Blog
March 08, 2017
Luke Parnell, pharmacy program liaison
We’re not talking peanuts: Carfentanil, fentanyl and heroin

Carfentanil is a synthetic opioid that is 80 times more potent than fentanyl and 8,000 times more potent than heroin. Having been created and used as an elephant tranquilizer in China, it has now found its way into the hands of the public. This dru…

March 08, 2017 by Luke Parnell, pharmacy program liaison
Load more
End of results.
Loading...